Equity · Healthcare
CTEV
NYSEClaritev (CTEV)
The line runs 34 USD on 10 August through 24 USD on 13 October, on a scale from 20 to 50. Days the market did not trade hold the previous close, flat.
- Market cap
- 406.7M USD
- Revenue, year to Dec 2025
- 965.4M USD
- EPS, diluted, year to Dec 2025
- −17.30 USD
- 52-week range
- 13 USD – 72 USD
- Avg volume
- 7.2K
as of Oct 13, 2026
Have Claritev (CTEV) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Claritev insiders reported 4 open-market sales and 4 purchases (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest reported trade 26 Oct 2026
Buys 4Sells 4Net bought $2.55MOther filings 3
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 26 Oct 2026 | ARES MANAGEMENT LLC10% Owner | Buy | 41,668 | 1.0M USD |
| 23 Oct 2026 | ARES MANAGEMENT LLC10% Owner | Buy | 100,000 | 2.4M USD |
| 15 Oct 2026 | Misencik TiffaniSVP, Chief Growth Officer | Sell | 5,812 | 138K USD |
| 21 Sep 2026 | Garis Douglas MichaelEVP&CFO | Sell | 9,025 | 276K USD |
| 28 Aug 2026 | Dalton TravisPres., CEO & Executive Chair | Buy | 1,950 | 75K USD |
| 27 Aug 2026 | Dalton TravisPres., CEO & Executive Chair | Buy | 4,500 | 175K USD |
| 14 Aug 2026 | Misencik TiffaniSVP, Chief Growth Officer | Sell | 8,850 | 355K USD |
| 10 Aug 2026 | Mintz William B.SVP, Chief Strategy Officer | Sell | 8,431 | 289K USD |
| Bought | 4 open-market purchases | 148,118 | $3.61M | |
| Sold | 4 open-market sales | 32,118 | $1.06M |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Oct 2026 | Main Jennifer ElizabethDirector | Award | 3,113 | |
| 14 Oct 2026 | Misencik TiffaniSVP, Chief Growth Officer | Tax withheld | 9,994 | 239K USD |
| 14 Sep 2026 | Letham Thomas BenjaminDirector | Award | 2,880 |
Which funds hold Claritev (CTEV)?
6 of the 45 institutional funds we track reported a Claritev position for the quarter ended 30 Jun 2026 — a combined 10.0M USD; the latest of those filings landed 14 Aug 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 174,011 | 5.9M USD | +398.7% |
| Renaissance Technologies | Held (±25%) | 46,015 | 1.6M USD | −11.4% |
| Point72 Asset Management | Trimmed | 39,000 | 1.3M USD | −56.4% |
| Marshall Wace | Trimmed | 13,533 | 462K USD | −80.9% |
| Millennium Management | Trimmed | 9,936 | 339K USD | −48.7% |
| D. E. Shaw & Co. | New position | 9,580 | 327K USD | |
| Third Point | Exited |
What has been filed or recorded for Claritev (CTEV)?
The filings we hold for Claritev, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 258 shares | 6K USD notional · 0.002% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −3.49 USD | Revenue $257M |
| 30 Jun 2026 | Financials | Total assets | 4.8B USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −294.6M USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −4.41 USD | Revenue $245M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −17.30 USD | Revenue $965M |
| 31 Dec 2025 | Financials | Revenue | 965.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −284.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −17.30 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −4.23 USD | Revenue $246M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −3.81 USD | Revenue $242M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −4.38 USD | Revenue $231M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −101.92 USD | Revenue $931M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −24.25 USD | Revenue $230M |
Claritev (CTEV): frequently asked questions
What did Claritev shares close at?
Claritev closed at 24.00 USD on 13 Oct 2026, down 1.34% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Claritev’s market cap?
Claritev is worth 406.7M USD by market value as of 13 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Claritev’s revenue?
Claritev reported revenue of 965.4M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Claritev insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, Claritev insiders reported 4 open-market sales and 4 purchases (SEC Form 4). A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Claritev?
6 of the 45 funds we track reported a Claritev position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Renaissance Technologies and Point72 Asset Management. See Funds
When did Claritev last report earnings?
Claritev last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −3.49 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings